Jon Faiz Kayyem

Sits on 2 boards. Last updated September 28, 2026

Time on boards

Boards served
2
Current seats
2
Board service
6 years
Director since
2023

6 years of board service in total across 2 boards, counting each seat separately. Longest: Biodesix Inc., 3 years.

Biodesix Inc. Director
3 years · Since 2023
2 years · Since 2024

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Sep 23, 2026 Inhibrx Biosciences Inc. Open-market purchase +5,000 $100.00 $500,000
Sep 16, 2026 Inhibrx Biosciences Inc. Open-market purchase +5,000 $100.00 $500,000
Sep 8, 2026 Inhibrx Biosciences Inc. Open-market purchase +5,000 $113.52 $567,600
Mar 27, 2025 Inhibrx Biosciences Inc. Gift −90,000 — —
Dec 16, 2024 Inhibrx Biosciences Inc. Gift −500,000 — —
Dec 16, 2024 Inhibrx Biosciences Inc. Gift +250,000 — —
Dec 16, 2024 Inhibrx Biosciences Inc. Gift +250,000 — —
Dec 6, 2024 Inhibrx Biosciences Inc. Gift −52,000 — —
Nov 20, 2024 Inhibrx Biosciences Inc. Open-market purchase +18,750 $14.19 $266,063
Nov 20, 2024 Inhibrx Biosciences Inc. Open-market purchase +18,750 $14.19 $266,063
Nov 19, 2024 Inhibrx Biosciences Inc. Open-market purchase +34,843 $14.23 $495,816
Nov 19, 2024 Inhibrx Biosciences Inc. Open-market purchase +34,843 $14.23 $495,816
Jun 24, 2024 Inhibrx Biosciences Inc. Gift −89,050 — —
Jun 24, 2024 Inhibrx Biosciences Inc. Gift +10,000 — —
Jun 24, 2024 Inhibrx Biosciences Inc. Gift +10,000 — —

Questions about Jon Faiz Kayyem

What boards is Jon Faiz Kayyem on?

Jon Faiz Kayyem sits on the boards of Biodesix Inc. and Inhibrx Biosciences Inc.

How long has Jon Faiz Kayyem served on boards?

Our records show at least 6 years of board service across 2 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.